Search results for "Drug Safety"
FDA asks clinicians to limit prescriptions of acetaminophen
The FDA recommends that clinicians stop prescribing and dispensing combination drugs that contain more than 325 mg of acetaminophen per dose.
https://immattersacp.org/archives/2014/05/acetaminophen.htm
1 May 2014
New grass allergy treatment, opioid overdose solution
This update covers approval of an allergen extract to treat allergic rhinitis induced by grass pollen and of a handheld injector of naloxone for emergency treatment of known or suspected opioid overdose.
https://immattersacp.org/archives/2014/06/fda.htm
1 Jun 2014
New warning for testosterone, approval for inhaled insulin
This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014
Latest diabetes drugs have a learning curve
The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015
New opioid warnings, powdered glove ban
The FDA announced plans to add new warnings to opioids and to ban powdered medical gloves last week.
https://immattersacp.org/weekly/archives/2016/03/29/6.htm
29 Mar 2016
ACP recognizes quality improvement champions at Internal Medicine Meeting 2016
Member leaders and staff at ACP's Center for Quality selected awardees whose work has helped physicians implement practice transformation so as to achieve the quadruple aim, including better care, better patient outcomes, better value, and the promotion of physician well-being.
https://immattersacp.org/weekly/archives/2016/05/24/6.htm
24 May 2016
New safety labels added to entire class of fluoroquinolones
Oral and injectable fluoroquinolones are associated with side effects involving tendons, muscles, joints, nerves, and the central nervous system, an FDA safety review found. These side effects may occur hours to weeks after use and can be permanent.
https://immattersacp.org/weekly/archives/2016/08/02/5.htm
2 Aug 2016
Safe prescribing can lessen overdose risk
In what one commentator called an “appalling” finding, 90% of patients in a recent study admitted to a hospital with a prescription opioid overdose eventually received another opioid prescription##mdash;often from the same clinician. Efforts to improve safe prescribing hope to fix the problem.
https://immattersacp.org/archives/2016/10/overdose.htm
1 Oct 2016
Managing medications in patients with heart failure
Internists can provide a medical home to patients with heart failure so that medications and supplements are regularly assessed and managed, according to experts.
https://immattersacp.org/archives/2017/02/medications.htm
1 Feb 2017
New drug treats cancer based on biomarker, not location
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/07/new-drug-treats-cancer-based-on-biomarker-not-location.htm
1 Jul 2017